In the US market, price for Fusidic Acid increased by whooping 2.94% in the last quarter of 2024 and it continued to increase in January as well by half a percentage point. This resulted in the market to move in bullish direction and many factors were involved in this strengthening market trends of Fusidic Acid in the US market. One among them was continued purchasing of orders in large volumes despite the price being on higher side resulting in further increase in price percentage.

The demand for Fusidic Acid remained strong from the downstream industry for increase in production of pharmaceutical grade topical antibiotic applications as there was a surge observed in consumer market of healthcare and pharmaceutical segments. On the other hand, supply remained on the moderate side and barely supported increasing demands. The US importers were also on there feet and stocked their inventories to prepare for supply shortages that they might face from China, the exporter for Fusidic Acid, during their golden week. There was also increase in strategic management of inventories across the whole supply chain to meet and prepare for the high demands of buyer in market.

China also took this situation and credited on it by showing an increase in quotations. An upsurge in Sodium Fusidate was accompanied by increase in other physical processes involved in production of Fusidic acid. The shipment scenario at port of Shanghai-Ningbo was facing delay due to berthing congestion due to interference faced from strong seasonal winds, transit was smooth, and the US port conditions were normal. Together these combinations validate the market trends that were tracked by ChemAnalyst researchers.

ChemAnalyst further anticipate a stable market trend as supply and demand start to balance out at the beginning of year 2025, which is then forecasted to decline till March, marking the end of first quarter of year 2025. Fresh stock from Asia is expected to arrive amid the fresh buyer inquiries likely to help maintain this trend in leading to stability in the beginning of the year. Healthcare and pharmaceutical companies will likely maintain a consistent demand of Fusidic Acid orders, contributing to stable market trends. It is in February and March when disruptions and some constraints can be expected from Asia supply chain of Fusidic acid.

Industry players will likely postpone import for strategic planning for Fusidic Acid procurement and distribution, adopting a wait-and-watch approach for the upcoming summer month and resulting in a slight decline in the market of Fusidic acid towards the end of March.